Literature DB >> 18799168

Reversible extensive leukoencephalopathy in Sweet disease: a case report.

Kazuhiro Fukushima1, Akiyo Hineno, Minori Kodaira, Kazuko Machida, Wataru Ishii, Tomoki Kaneko, Hisashi Shimojo, Hisashi Uhara, Kanji Yamamoto, Hiroshi Morita, Kunihiro Yoshida, Shu-ich Ikeda.   

Abstract

Sweet disease, also known as acute febrile neutrophilic dermatosis, is an idiopathic multisystem inflammatory disorder characterised by erythematous skin lesions and fever. "Neuro-Sweet disease" is a rare central nervous system involvement that coexists with the characteristic cutaneous lesions of Sweet disease. Here, we report a case of Sweet disease complicated with acute encephalopathy. This case showed extensive lesions in the cerebral white matter on magnetic resonance imaging (MRI) and high protein concentration in the cerebrospinal fluid (CSF) without pleocytosis. After steroid therapy, the patient's clinical syndrome recovered completely with no significant neurological deficits or abnormal findings on brain MRI, and normalization of the high CSF protein concentration. Both clinical and MRI findings suggested that the marked leukoencephalopathy in this case was mainly due to reversible oedema rather than destructive structural alterations in the cerebral parenchyma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799168     DOI: 10.1016/j.jns.2008.08.006

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome.

Authors:  Neal S Parikh; Andrew D Schweitzer; Robert J Young; Ashley E Giambrone; John Lyo; Sasan Karimi; Anna Knobel; Ajay Gupta; Babak B Navi
Journal:  J Neurol Sci       Date:  2017-06-29       Impact factor: 3.181

2.  Two cases of possible neuro-Sweet disease with meningoencephalitis as the initial manifestation.

Authors:  Go Makimoto; Yasuhiro Manabe; Chizuru Yamakawa; Daiki Fujii; Yasuko Ikeda-Sakai; Hisashi Narai; Nobuhiko Omori; Koji Abe
Journal:  Neurol Int       Date:  2012-02-09

3.  Increase of a wide range of bioactive substances in an active phase of neuro-Sweet disease.

Authors:  Hiroi Kusaka; Katsuya Nagatani; Takeo Sato; Seiji Minota
Journal:  BMJ Case Rep       Date:  2020-04-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.